D
BioNTech SE BNTX
$101.81 $3.053.09% NASDAQ
Recommendation
Prev Close
$98.76
Volume
978,286
Avg Vol (90D)
823,051
Market Cap
$23.70B
Dividend & Yield
--
52-Week Range
$76.53 - $131.49
P/E (TTM)
--
EPS (TTM)
-$3.00
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations
4/21/2025 - GuruFocus
Marshall Wace LLP Acquires 37,177 Shares of BioNTech SE (NASDAQ:BNTX)
4/21/2025 - Ticker Report
Bridgewater Associates LP Increases Holdings in BioNTech SE (NASDAQ:BNTX)
4/19/2025 - Ticker Report
Finward Bancorp Makes New Investment in BioNTech SE (NASDAQ:BNTX)
4/18/2025 - MarketBeat
BioNTech (NASDAQ:BNTX) Trading Down 2.4% - Time to Sell?
4/17/2025 - MarketBeat
Bank of America Securities Remains a Buy on BioNTech SE (BNTX)
4/17/2025 - TipRanks Financial Blog
Kennedy Capital Management LLC Purchases 9,964 Shares of BioNTech SE (NASDAQ:BNTX)
4/17/2025 - MarketBeat
2,965 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by Finward Bancorp
4/16/2025 - Ticker Report
Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength?
4/15/2025 - Zacks Investment Research
BioNTech SE American Depositary Share (BNTX, $102.34) price may drop as it broke higher Bollinger Band on Apr 14, 2025
4/15/2025 - Tickeron - Stocks
Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?
4/14/2025 - Zacks Investment Research
How The Parts Add Up: FTQI Headed For $23
4/14/2025 - ETF Channel
Here's Why Summit Therapeutics Stock Soared 15% on Friday
4/14/2025 - Zacks Investment Research
Scotia Capital Inc. Purchases 30,143 Shares of BioNTech SE (NASDAQ:BNTX)
4/11/2025 - Ticker Report
Arrowstreet Capital Limited Partnership Buys New Position in BioNTech SE (NASDAQ:BNTX)
4/11/2025 - MarketBeat
Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?
4/10/2025 - Zacks Investment Research
Fmr LLC Boosts Stock Holdings in BioNTech SE (NASDAQ:BNTX)
4/10/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $94.14) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 9, 2025
4/10/2025 - Tickeron - Stocks
BioNTech SE American Depositary Share (BNTX, $94.14) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Barbara Weber, M.D., Elected to ITM Supervisory Board
4/9/2025 - Globe Newswire
Aristides Capital LLC Has $2.05 Million Holdings in BioNTech SE (NASDAQ:BNTX)
4/8/2025 - MarketBeat
Aristides Capital LLC Has $2.05 Million Holdings in BioNTech SE (NASDAQ:BNTX)
4/6/2025 - Ticker Report
HC Wainwright Brokers Boost Earnings Estimates for BioNTech
4/6/2025 - MarketBeat
Cinctive Capital Management LP Buys Shares of 14,760 BioNTech SE (NASDAQ:BNTX)
4/6/2025 - MarketBeat
BioNTech SE American Depositary Share (BNTX, $88.05) RSI Indicator left the oversold zone on April 04, 2025
4/5/2025 - Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
$2.98B
EBITDA (TTM)
-$1.12B
EBIT (TTM)
-$1.39B
Net Income (TTM)
-$717.13M
Balance Sheet
Total Assets (Q)
$23.33B
Total Debt (Q)
$263.17M
Total Liabilities (Q)
$3.23B
Book Value Per Share (Q)
$83.75
Cash Flow
Cash from Operations (TTM)
$210.70M
Cash from Investing (TTM)
-$2.27B
Cash from Financing (TTM)
-$49.58M
Net Change in Cash (TTM)
-$2.09B
Filings
Filing Date
Monday, March 10, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
0.86
7-Day Total Return
8.15%
30-Day Total Return
-6.41%
60-Day Total Return
-16.63%
90-Day Total Return
-16.36%
Year to Date Total Return
-11.70%
1-Year Total Return
18.15%
2-Year Total Return
-17.36%
3-Year Total Return
-35.58%
5-Year Total Return
137.02%
52-week Low
Aug 05, 2024 - $76.53
52-week High
Sep 17, 2024 - $131.49
Valuation
Market Cap
$23.70B - Large Cap
Enterprise Value
$6.59B
Price/Sales (TTM)
7.97
Price/Book (Q)
1.18
Dividends and Shares
Shares Outstanding
240.28M
Dividend Per Share (Most Recent)
$1.55
Dividend Per Share (TTM)
--
Corporate Info
Website
www.biontech.de
Phone Number
49 6131 9084
Address
An der Goldgrube 12
Mainz, 55131
Country
Germany
Year Founded
2008
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical... more
NASDAQ 04/21/2025 4:00PM Eastern Quotes delayed